The drug company lowered its 2010 revenue forecast, citing weakness in the euro
30 July 2010
No CommentToday’s column includes the latest quarterly results from Amgen, Inc. (AMGN), a wave of post-earnings price-target adjustments on Potash Corp…(Read More)
Popular Posts
- Howard Marks Possibly Looking for Oaktree NYSE Listing This Summer
- Intevac Inc. (IVAC) Chairman of the Board Norman H Pond sells 9,000 Shares
- The SPX and COMP each gave up more than 2% by the time the bell mercifully rang
- THE ENSIGN GROUP, INC. (ENSG) Chairman of the Board Family Trust Dated 8/17/92 Christensen …
- WidePoint Corp. (WYY) CFO, VP, Secretary James T Mccubbin sells 200,000 Shares
Recent Posts
- PepsiCo: Management Stands Behind “Power of One”
- When to Sell Stocks - a value / fundamental perspective
- 14 Services Stocks With Strongest Earnings Growth And Best Dividends
- Trade Data: Is China Losing Its Steam?
- Thoughts on ArcelorMittal
- Top Growth stocks from Warren Buffett
- Top 5 conviction picks from Steven Romick
- Download February Issue of Micro-Cap Magic Formula Newsletter
MarketWatch.com - Top Stories
- Greece votes to approve austerity measures
- Craig Stephen's This Week in China: China posts worrying January numbers
Bernie Schaeffer's Market Commentaries
GuruFocus New Articles
- PepsiCo: Management Stands Behind "Power of One"
- When to Sell Stocks - a value / fundamental perspective
Stocks News and Information on Yahoo! Finance
